Benzinga's Top Downgrades

Analysts at Oppenheimer downgraded
Raptor Pharmaceutical Corp.RPTP
from Perform to Underperform. Raptor Pharmaceutical's shares closed at $15.79 on Thursday. Analysts at Barclays downgraded
Centene CorpCNC
from Overweight to Equal-weight. The price target for Centene has been lowered from $88.00 to $81.00. Centene shares closed at $74.45 on Thursday. Analysts at UBS downgraded
Celanese CorporationCE
from Buy to Neutral. The price target for Celanese has been raised from $69.00 to $74.00. Celanese shares closed at $73.72 on Thursday. Analysts at Morgan Stanley downgraded
Intuitive Surgical, Inc.ISRG
from Equal-weight to Underweight. Intuitive Surgical shares closed at $486.29 on Thursday. Citigroup downgraded
BT Group plc (ADR)BT
from Buy to Neutral. BT Group's shares closed at $71.16 on Thursday. FBR Capital downgraded
VMware, Inc.VMW
from Outperform to Market Perform. VMware shares closed at $85.17 on Thursday. Guggenheim Securities downgraded
Aegerion Pharmaceuticals, Inc.AEGR
from Neutral to Sell. Aegerion Pharmaceuticals' shares closed at $18.59 on Thursday. KeyBanc downgraded
CIRCOR International, Inc.CIR
from Overweight to Sector Weight. CIRCOR International's shares closed at $52.87 on Thursday. BB&T Capital downgraded
HORSEHEAD HOLDING CORP.ZINC
from Buy to Hold. Horsehead Holding's shares closed at $11.45 on Thursday. Stephens & Co. downgraded
ACI Worldwide IncACIW
from Overweight to Equal-weight. The price target for ACI Worldwide is set to $26. ACI Worldwide shares closed at $24.33 on Thursday.

Posted In: Top DowngradesDowngradesAnalyst Ratings